Results 151 to 160 of about 484,866 (343)

Parkinson’s Disease: Time, Place, Person and Survival

open access: yesSiriraj Medical Journal, 2009
-
Weerasak Muangpaisan   +3 more
openaire   +1 more source

Additional file 1 of Altered gut microbiota and inflammatory cytokine responses in patients with Parkinsonâ s disease

open access: yes, 2019
: Supplementary methods. (DOCX 21Â kb)
Chin-Hsien Lin   +10 more
openaire   +1 more source

Photothermal Hydrogel with Mn3O4 Nanoparticles Alleviates Intervertebral Disc Degeneration by Scavenging ROS and Regulating Extracellular Matrix Metabolism

open access: yesAdvanced Functional Materials, EarlyView.
The MPTT‐nanozyme‐hydrogel system (Mn3O4@ChS‐HA) provides a multifunctional therapeutic strategy for intervertebral disc degeneration (IVDD), effectively targeting oxidative stress and enhancing AF repair by restoring extracellular matrix (ECM) and redox homeostasis.
Yangyang Chen   +13 more
wiley   +1 more source

Parkinsonisms and Glucocerebrosidase Deficiency: A Comprehensive Review for Molecular and Cellular Mechanism of Glucocerebrosidase Deficiency

open access: yesBrain Sciences, 2019
In the last years, lysosomal storage diseases appear as a bridge of knowledge between rare genetic inborn metabolic disorders and neurodegenerative diseases such as Parkinson’s disease (PD) or frontotemporal dementia. Epidemiological studies helped
Emilia M. Gatto   +4 more
doaj   +1 more source

Engineering a Single Amino Acid Bionanozyme for Ultrasensitive Detection of Biomarkers: A WHO‐REASSURE‐ Aligned Approach

open access: yesAdvanced Functional Materials, EarlyView.
A unique 2D bionanozyme, engineered from a single amino acid and copper ions, demonstrates peroxidase‐mimicking catalytic activity. This efficient and simple bionanozyme allows for ultrasensitive, equipment‐free visual detection of key biomarkers in both test and real samples, meeting the WHO‐REASSURE standards for practical diagnostic applications ...
Subrat Vishwakarma   +5 more
wiley   +1 more source

Bromocriptine in the Management of End of Dose Deterioration in Parkinson’s Disease [PDF]

open access: bronze, 1984
J. David Grimes   +5 more
openalex   +1 more source

Additional file 1: of Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinsonâ s disease

open access: yes, 2016
Supplementary Materials and Methods. (PDF 401Â kb)
Majbour, Nour   +13 more
openaire   +1 more source

Transducer Materials Mediated Deep Brain Stimulation in Neurological Disorders

open access: yesAdvanced Functional Materials, EarlyView.
This review discusses advanced transducer materials for improving deep brain stimulation (DBS) in neurological disorders. These materials respond to light, ultrasound, or magnetic fields, enabling precise, less invasive neuromodulation. Their stimulus‐responsive properties enhance neural control and adaptive therapy, paving the way for next‐generation ...
Di Zhao   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy